Clarity Pharmaceuticals

Clarity is a clinical stage radiopharmaceutical company developing next-generation products to address the growing need for the use of radiopharmaceuticals in oncology. Clarity is a global leader in Targeted Copper Theranostics (TCT), developed with its proprietary SAR Technology platform. TCT are the next-generation disruptive platform in radiopharmaceuticals that employ the perfect pairing of copper-64 and copper-67 for diagnosis and therapy. TCT deliver a compelling combination of high accuracy and high precision in the treatment of a range of cancers, as well as providing supply and logistical advantages over current theranostics. TCT provide a highly efficacious, scalable, and cost-effective way to...

Antibody and peptide imaging,pharmaceutical imaging,companion diagnostics,drug development,radiopharmaceuticals,nuclear medicine,and targeted therapy

Clarity pharmaceuticals operates in the Biotechnology research industry.

Clarity pharmaceuticals's revenue is 11m - 100m

Clarity pharmaceuticals has 51 - 200 employees.